Kura Oncology Inc Stock
Kura Oncology Inc Stock
Kura Oncology Inc dominated the market today, gaining €0.61 (3.330%).
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Kura Oncology Inc stock is not clear.
With a target price of 20 € there is a slightly positive potential of 5.71% for Kura Oncology Inc compared to the current price of 18.92 €.
Our community identified positive and negative aspects for Kura Oncology Inc stock for the coming years. 1 users see the criterium "Business model" as a plus for the Kura Oncology Inc stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Kura Oncology Inc in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
S********** s********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Kura Oncology Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Kura Oncology Inc | 3.330% | 7.837% | 0.826% | 105.652% | 47.813% | -14.775% | 40.921% |
| Ardelyx Inc. | 28.120% | 34.723% | 18.969% | 89.624% | 39.758% | 44.250% | - |
| Evolus Inc | 10.280% | 12.381% | -5.600% | 60.544% | 30.387% | 60.544% | - |
| Salarius Pharmaceuticals Inc. | 11.650% | 7.981% | 17.949% | -67.606% | -17.117% | -98.248% | -99.993% |